Cencora (COR) | Stock Overview & Key Data
Cencora Performance Comparison
Stock Range
Today's Range
Low: $302.42
High: $306.28
on August 21, 2025
52 Week Range
Low: $218.65
High: $309.35
on October 7, 2024
on May 7, 2025
All-Time High: $309.35 on May 5, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$56.7B
EPS
8.65
P/E Ratio (TTM)
33.80
Forward P/E
17.87
P/B Ratio
55.93
PEG Ratio
17.87
Div. Yield
0.54%
ROE
141.78%
Beta
0.600
Debt to Equity
827.73
Financial Highlights
Profitability
Gross Margin
4.06%
Operating Margin
1.34%
Profit Margin
0.55%
Returns and Earnings
Return on Assets (TTM)
2.97%
Return on Equity (TTM)
141.78%
EBITDA
$4.7B
Net Income (TTM)
$1.7B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1,591.39
Quarterly Revenue Growth (YoY)
10.30%
Quarterly Earnings Growth (YoY)
70.60%
Dividend Information
Last 12-Month Dividend
$1.61
Current Dividend Yield
0.54%
3-Year Average Dividend Yield
0.26%
3-Year Average Annual Dividend
$1.84
3-Year Total Dividends
$5.52
Ex-Dividend Date
February 14, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Cencora COR | 56.66B Large-cap | 2.84% | 3.61% | 4.07% | 25.60% | 34.92% | 27.55% | 107.42% | 210.85% |
| McKesson MCK | 84.20B Large-cap | 4.78% | -0.73% | -1.77% | 18.12% | 24.69% | 27.86% | 97.88% | 358.83% |
| Cardinal Health CAH | 35.73B Large-cap | 0.90% | -4.42% | -1.13% | 19.29% | 28.43% | 38.50% | 124.22% | 200.14% |
| Henry Schein HSIC | 8.22B Mid-cap | 0.44% | -1.25% | -5.37% | -11.69% | -0.50% | -3.69% | -7.06% | 2.66% |
| Patterson Companies PDCO | 2.77B Mid-cap | -0.03% | 0.55% | 1.23% | 47.16% | 1.72% | 21.58% | 1.82% | 87.72% |
| Owens & Minor OMI | 408.62M Small-cap | -5.93% | -34.37% | -26.06% | -18.33% | -60.47% | -68.97% | -83.26% | -69.31% |
Ownership & Short Interest
Insider Ownership
5.71%
Institutional Ownership
93.87%
Shares Short
7M
Short Ratio
3.24
Short % of Shares Outstanding
5.89%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Cencora Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Cencora would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is COR's 52-week high and low?
- In the last 52 weeks, Cencora reached a high of $309.35 (on May 7, 2025) and a low of $218.65 (on October 7, 2024).
- What is the market cap and P/E ratio for COR?
- Curious about Cencora's size and valuation? Its market capitalization stands at 56.66B. When it comes to valuation, the P/E ratio (trailing twelve months) is 33.80, and the forward P/E (looking ahead) is 17.87.
- Does COR pay dividends? If so, what's the yield?
- Yes, Cencora is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.54%, and the company has paid an average of $1.84 per share annually over the past 3 years.
- Who are Cencora's main competitors or similar companies to consider before investing?
When looking at Cencora, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return McKesson
MCK84.20B Healthcare Medical Distribution 27.86% 97.88% Cardinal Health
CAH35.73B Healthcare Medical Distribution 38.50% 124.22% Henry Schein
HSIC8.22B Healthcare Medical Distribution -3.69% -7.06% Patterson Companies
PDCO2.77B Healthcare Medical Distribution 21.58% 1.82% Owens & Minor
OMI408.62M Healthcare Medical Distribution -68.97% -83.26% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cencora Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Cencora's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 141.78%, the Debt to Equity ratio from the most recent quarter is 827.73, and its Gross Profit Margin stands at 4.06%.
- What is the recent revenue and earnings growth for COR?
- Looking at Cencora's growth, its revenue over the trailing twelve months (TTM) was $310B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.30%, and quarterly earnings saw a YoY growth of 70.60%.
- How much of COR stock is held by insiders and institutions?
- Wondering who owns Cencora stock? Company insiders (like executives and directors) hold about 5.71% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 93.87%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.